The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Daxas



AstraZeneca ABEU/1/10/636/008

Main Information

Trade NameDaxas
Active SubstancesRoflumilast
Dosage FormTablet
Licence HolderAstraZeneca AB
Licence NumberEU/1/10/636/008

Group Information

ATC CodeR03DX Other systemic drugs for obstructive airway diseases
R03DX07 roflumilast

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back